文献速递冠心病心力衰竭与心肌病

ORBI风险评分预测直接PCI后STEMI患者院内心源性休克

Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
PubMed 文献 · Eur Heart J · 2018-01-01

基于ORBI队列6838例入院无休克并接受直接PCI的STEMI患者推导ORBI风险评分,在RICO队列2208例中外部验证。评分含11个变量,分四层风险,院内CS发生率分别为1.3%、6.6%、11.7%、31.8%,验证队列C统计量0.84和0.80。

要点

  • ORBI评分含11项变量,可分层预测院内CS风险。
  • 评分≥13为高危,推导队列CS发生率31.8%,验证队列34.1%。
  • C统计量推导0.84、验证0.80,区分度良好且校准充分。

核心结论

  • ORBI风险评分是识别STEMI直接PCI后院内发生CS高危患者的简便有效工具。

研究设计与样本

  • 推导队列为ORBI注册中6838例入院无CS并接受直接PCI的STEMI患者。
  • 外部验证队列为RICO注册中2208例患者。
  • 采用逐步多因素logistic回归构建评分。

主要发现

  • 11个变量与院内CS独立相关:年龄>70岁、既往卒中/TIA、入院心脏骤停、前壁STEMI、首次医疗接触至pPCI延迟>90 min、Killip分级、心率>90/min、收缩压<125 mmHg且脉压<45 mmHg、血糖>10 mmol/L、左主干罪犯病变、pPCI后TIMI血流<3级。
  • 推导队列四层风险(0-7、8-10、11-12、≥13)院内CS发生率分别为1.3%、6.6%、11.7%、31.8%。
  • 验证队列对应四层风险院内CS发生率分别为3.1%、10.6%、18.1%、34.1%。
  • 区分度:推导队列c-statistic 0.84,验证队列0.80,两队列校准充分。

关键数值与推荐

  • 风险分层:低危0-7分,低至中危8-10分,中至高危11-12分,高危≥13分。

临床怎么用

  • 可用于STEMI直接PCI后患者院内CS的早期风险分层,辅助抢先临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To derive and validate a readily useable risk score to identify patients at high-risk of in-hospital ST-segment elevation myocardial infarction (STEMI)-related cardiogenic shock (CS). METHODS AND RESULTS: In all, 6838 patients without CS on admission and treated by primary percutaneous coronary intervention (pPCI), included in the Observatoire Régional Breton sur l'Infarctus (ORBI), served as a derivation cohort, and 2208 patients included in the obseRvatoire des Infarctus de Côte-d'Or (RICO) constituted the external validation cohort. Stepwise multivariable logistic regression was used to build the score. Eleven variables were independently associated with the development of in-hospital CS: age >70 years, prior stroke/transient ischaemic attack, cardiac arrest upon admission, anterior STEMI, first medical contact-to-pPCI delay >90 min, Killip class, heart rate >90/min, a combination of systolic blood pressure <125 mmHg and pulse pressure <45 mmHg, glycaemia >10 mmol/L, culprit lesion of the left main coronary artery, and post-pPCI thrombolysis in myocardial infarction flow grade <3. The score derived from these variables allowed the classification of patients into four risk categories: low (0-7), low-to-intermediate (8-10), intermediate-to-high (11-12), and high (≥13). Observed in-hospital CS rates were 1.3%, 6.6%, 11.7%, and 31.8%, across the four risk categories, respectively. Validation in the RICO cohort demonstrated in-hospital CS rates of 3.1% (score 0-7), 10.6% (score 8-10), 18.1% (score 11-12), and 34.1% (score ≥13). The score demonstrated high discrimination (c-statistic of 0.84 in the derivation cohort, 0.80 in the validation cohort) and adequate calibration in both cohorts. CONCLUSION: The ORBI risk score provides a readily useable and efficient tool to identify patients at high-risk of developing CS during hospitalization following STEMI, which may aid in further risk-stratification and thus potentially facilitate pre-emptive clinical decision making.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Auffret V, Cottin Y, Leurent G, et al. Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score. Eur Heart J. 2018. PMID: 29554243. doi:10.1093/eurheartj/ehy127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。